898 abstracts found.



Results filter



What can we learn from circulating tumour cells in lung cancer – biomarkers, mouse models, drug resistance and heterogeneity

Year:

Session type:

Caroline Dive1,
1Cancer Research UK Manchester Institute, Manchester, UK



Neutral and biased replacement of intestinal stem cells

Year:

Session type:

Doug Winton1,
1Cancer Research UK Cambridge Institute, Cambridge, UK



Proton therapy: pushing the frontiers of radiotherapy

Year:

Session type:

Tony Lomax1,
1Centre for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland



Introduction: Inflammation and cancer

Year:

Session type:

Fran Balkwill1,
1Queen Mary, University of London, London, UK



Introduction: Cancer evolution

Year:

Session type:

Charles Swanton1,2,
1Cancer Research UK London Research Institute, London, UK,2niversity College London Cancer Institute, London, UK



Image guided radiation therapy

Year:

Session type:

Uwe Oelfke1,
1The Institute of Cancer Research UK and The Royal Marsden NHS Foundation Trust, London, UK



The targets for tumour immunotherapy mediated by the inflammatory properties of vesicular stomatitis virus (VSV)-based antigen presentation depend upon the tumour’s anatomical site

Year:

Session type:

Richard Vile1,
1Mayo Clinic, Rochester, USA



Making sense of intratumour heterogeneity: evidence of a ‘Big Bang’ tumour expansion

Year:

Session type:

Andrea Sottoriva1,
1The Institute of Cancer Research, London, UK



Introduction: Optimising care for those living with and beyond cancer – where does primary care fit in?

Year:

Session type:

Eila Watson1,
1Oxford Brookes University, UK, Oxford, UK



Co-targeting angiogenesis and immunosuppressive cell networks to improve anti-cancer therapy

Year:

Session type:

Michele De Palma1,
The Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland (1)

Page 2 of 90« First...2...25...Last »